Hepatitis C Drug Market: expanding in Asia Pacific, Latin America and Middle East & Africa due to prevalence of the disease.

Publish in

Business

260 views

Please download to get full document.

View again

of 15
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Share
Description
Global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% by 2021
Transcript
  • 1. Published By: Zion Research Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 Joel John 3422 SW 15 Street, Suit #8138, Deerfield Beach, Florida 33442, USA Tel: +1-386-310-3803 Toll Free: 1-855-465-4651 www.marketresearchstore.com sales@marketresearchstore.com
  • 2. Hepatitis C Drug Market sales@marketresearchstore.com Zion Research has published a new report titled “Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” According to the report, global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% between 2016 and 2021. Request Report Sample http://www.marketresearchstore.com/report/hepatitis-c- drug-market-z62423 HCV is a major public health problem that attacks the liver and leads to inflammation. Certain drugs, toxins, heavy alcohol use, bacterial and viral infections can cause hepatitis infection. The most common types of hepatitis infections are Hepatitis A, Hepatitis B, and Hepatitis C and they are caused by three dissimilar dissimilar viruses. Although each virus can cause similar symptoms, they have different modes of transmission and can affect the liver differently.
  • 3. Hepatitis C Drug Market sales@marketresearchstore.com Hepatitis C infection can bring both acute and chronic hepatitis disease. Approximately, 80% of patients get chronically infected with hepatitis C disease. Hepatitis C infection (HCV) spreads through the blood of infected individual by the use of shared needles or supplies used to infuse drugs. Vaccines are available only for Hepatitis A and Hepatitis B viruses. Research into the development of a vaccine for hepatitis C is under way. Hepatitis C Drug Market: Inquiry for buying report http://www.marketresearchstore.com/report/hepatitis-c-drug- market-z62423#InquiryForBuying The prevalence of the infection, new productive treatments, relatively lesser time of treatment from before, and rising government subsidizing, can drive the hepatitis C drug market. Lack of awareness and information about HCV and treatment expense of disease can influence the hepatitis C market. In the last few years a couple of new drugs have been launched in the market which has huge success and captured maximum market share of the hepatitis C market. However, cost of these drugs is too high. Hospitals, private labs, physician offices, public health labs, and blood banks are the key application of hepatitis C drug market.
  • 4. Hepatitis C Drug Market sales@marketresearchstore.com North America was one of the fastest growing hepatitis C drug markets across the world with more than 40% share of the total revenue generated in 2015. U. S. is the largest revenue contributor for worldwide Hepatitis C market. Government funding for drug development will continue to play an essential role in the growth of U.S. HCV treatment market. Europe was the second major market for Hepatitis C in 2015. Ongoing research and development in pharmaceutical industry for hepatitis C drug development is expected to propel the market growth in the coming years. Moreover, interest for Hepatitis C medication is expanding in Asia Pacific, Latin America and Middle East and Africa due to prevalence of the disease in the regions combined with expenditure on healthcare infrastructure. Hepatitis C Drug Market: Browse the full report at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423 Harvoni and Sovaldi are newly discovered drugs for Hepatitis C. Marketed by pharmaceutical giant Gilead Sciences and has more than 95% cure rate. The problem with this drug is its high
  • 5. Hepatitis C Drug Market sales@marketresearchstore.com cost, Harvoni drug is one of the expensive drug in the world. Some of the key player in the hepatitis C drug market includes Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb. The report segments the global hepatitis C drug market as Hepatitis C Drug Market: Table of Content http://www.marketresearchstore.com/report/hepatitis-c-drug-market- z62423#tableOfContent Hepatitis C Drug Market: Application Segment Analysis  Hospitals  Private labs  Physician offices
  • 6. Hepatitis C Drug Market sales@marketresearchstore.com  Public health labs  Blood banks Hepatitis C Drug Market: Regional Segment Analysis  North America o U.S.  Europe o Germany o UK o France  Asia Pacific o China o Japan o India  Latin America o Brazil
  • 7. Hepatitis C Drug Market sales@marketresearchstore.com  Middle East and Africa  Chapter 1. Preface o 1.1. Report description and scope o 1.2. Research scope o 1.3. Research methodology  1.3.1. Market research process  1.3.2. Market research methodology  Chapter 2. Executive Summary o 2.1. Global hepatitis C drug market, 2015 - 2021, (USD Billion) o 2.2. Hepatitis C drug: market snapshot  Chapter 3. Hepatitis C Drug Market: Industry Analysis o 3.1. Hepatitis C drug : Market dynamics o 3.2. Market Drivers  3.2.1. Increasing incidences of the disease  3.2.2. New efficient therapies and comparatively smaller period of treatment  3.2.3. Rising government funding o 3.3. Restraints
  • 8. Hepatitis C Drug Market sales@marketresearchstore.com  3.3.1. Lack of awareness and information about HCV  3.3.2. Treatment cost  3.3.3. Threat related with regulation and development of drug o 3.4. Opportunity  3.4.1. Advancing technologies and ongoing research o 3.5. Porter’s Five Forces Analysis o 3.6. Market Attractiveness Analysis  3.6.1. Market attractiveness analysis by application segment  3.6.2. Market attractiveness analysis by regional segment  Chapter 4. Global hepatitis C drug market: Competitive Landscape Hepatitis C Drug Market: Browse the full report at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423 o 4.1. Company Market Share Analysis  4.1.1. Global hepatitis C drug market: company market share, 2015 o 4.2. Strategic Development  4.2.1. Acquisitions & Mergers  4.2.2. New Product Launch  4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures  4.2.4. Research and Development, Product and Regional Expansion
  • 9. Hepatitis C Drug Market sales@marketresearchstore.com o 4.3. Price Trend Analysis o 4.4. Product Portfolio o 4.5. Patent Analysis (2011-2016)  4.5.1. Patent Trend  4.5.2. Patent Share by company  4.5.3. By Region  Chapter 5. Global hepatitis C market: Application Overview o 5.1. Global hepatitis C drug market share, by application, 2015 and 2021 o 5.2. Global hepatitis C drug market for hospitals, 2015 - 2021(USD Billion) o 5.3. Global hepatitis C drug market for private labs , 2015 - 2021 (USD Billion) o 5.4. Global hepatitis C drug market for physician offices, 2015 - 2021 (USD Billion) o 5.5. Global hepatitis C drug market for public health labs, 2015 - 2021 (USD Billion) o 5.6. Global hepatitis C drug market for blood banks, 2015 - 2021 (USD Billion)  Chapter 6. Global hepatitis C drug market: Regional Analysis o 6.1. Global hepatitis C drug market: Regional overview  6.1.1. Global hepatitis C drug market share, by region, 2015 and 2021 o 6.2. North America  6.2.1. North America hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.2.2. U.S.  6.2.3. U.S. hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)
  • 10. Hepatitis C Drug Market sales@marketresearchstore.com o 6.3. Europe  6.3.1. Europe hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.3.2. UK  6.3.2.1. UK hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.3.3. France  6.3.3.1. France hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.3.4. Germany  6.3.4.1. Germany hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion) Hepatitis C Drug Market: Browse the full report at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423 o 6.4. Asia Pacific  6.4.1. Asia-Pacific hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.4.2. China
  • 11. Hepatitis C Drug Market sales@marketresearchstore.com  6.4.2.1. China hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.4.3. Japan  6.4.3.1. Japan hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.4.4. India  6.4.4.1. India hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion) o 6.5. Latin America  6.5.1. Latin America hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  6.5.2. Brazil  6.5.2.1. Brazil hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion) o 6.6. Middle East & Africa  6.6.1. Middle East & Africa hepatitis C drug market revenue, by application, 2015 – 2021 (USD Billion)  Chapter 7. Company Profiles o 7.1. Merck & Co  7.1.1. Overview  7.1.2. Financials  7.1.3. Product portfolio
  • 12. Hepatitis C Drug Market sales@marketresearchstore.com  7.1.4. Business strategy  7.1.5. Recent developments o 7.2. Kenilworth  7.2.1. Overview  7.2.2. Financials  7.2.3. Product portfolio  7.2.4. Business strategy  7.2.5. Recent developments o 7.3. Roche  7.3.1. Overview  7.3.2. Financials  7.3.3. Product portfolio  7.3.4. Business strategy  7.3.5. Recent developments o 7.4. Basel Glaxosmith  7.4.1. Overview  7.4.2. Financials  7.4.3. Product portfolio  7.4.4. Business strategy  7.4.5. Recent developments o 7.5. Gilead Sciences  7.5.1. Overview
  • 13. Hepatitis C Drug Market sales@marketresearchstore.com  7.5.2. Financials  7.5.3. Product portfolio  7.5.4. Business strategy  7.5.5. Recent developments o 7.6. Abbvie  7.6.1. Overview  7.6.2. Financials  7.6.3. Product portfolio  7.6.4. Business strategy  7.6.5. Recent developments o 7.7. Bristol- Myers Squibb.d  7.7.1. Overview  7.7.2. Financials  7.7.3. Product portfolio  7.7.4. Business strategy  7.7.5. Recent developments o 7.8. Johnson & Johnson  7.8.1. Overview  7.8.2. Financials  7.8.3. Product portfolio  7.8.4. Business strategy  7.8.5. Recent Developments
  • 14. Hepatitis C Drug Market sales@marketresearchstore.com  Chapter 8. Patents o 8.1. U.S. (US Patents) o 8.2. Europe (EP documents) o 8.3. Japan (Abstracts of Japan) o 8.4. Global (WIPO (PCT)) Hepatitis C Drug Market: Browse the full report at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423
  • 15. Hepatitis C Drug Market sales@marketresearchstore.com Market Research Store Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA Tel: +1-386-310-3803 Tel: +1-855-465-4651 (US/CAN TOLL FREE) Email: sales@marketresearchstore.com Web : http://www.marketresearchstore.com
  • Related Search

    Next Document

    10.doc

    Related Documents
    View more...
    We Need Your Support
    Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

    Thanks to everyone for your continued support.

    No, Thanks